Related Experiment Video
Updated: Jun 4, 2026
Optimizing Tubulin Yield from Porcine Brain Tissue
Published on: October 11, 2024
[Progress in the study of tubulin inhibitors]
1Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China.
Abstract:
Microtubule is one of the key components of the cytoskeleton and plays an important role in the maintenance of cell shape and the process of signal transduction and mitosis. Due to the extreme importance of microtubule in the process of mitosis, tubulin becomes one of the most important targets for development of new anticancer drugs and tubulin inhibitors are used for the treatment of cancer nowadays. These inhibitors have antitumor activity by inhibiting or promoting the assembly of tubulin to microtubules and interfering the process of cell mitosis. This review summarized the research progress of the tubulin inhibitors, especially the introduction of the tubulin inhibitors of pharmacological activities and the progress of clinical research. Also, the development trend of these inhibitors is discussed.
Insights
Tubulin inhibitors target microtubules, crucial for cell division, offering new anticancer drug strategies. This review covers their pharmacological activities, clinical progress, and future development trends.
Area of Science:
- Cell Biology
- Biochemistry
- Pharmacology
Context:
- Microtubules, essential cytoskeleton components, are vital for cell shape, signal transduction, and mitosis.
- Tubulin, the microtubule protein, is a key target for novel anticancer drug development.
- Current cancer therapies utilize tubulin inhibitors to disrupt mitosis and induce antitumor activity.
Purpose:
- To review the research progress of tubulin inhibitors.
- To introduce the pharmacological activities of tubulin inhibitors.
- To discuss the clinical research progress and future development trends of tubulin inhibitors.
Summary:
- Tubulin inhibitors function by modulating tubulin assembly into microtubules, thereby interfering with cell mitosis.
- This review details the research advancements in tubulin inhibitors, focusing on their mechanisms and clinical applications.
- The discussion encompasses the current state of clinical research and future directions for tubulin inhibitor development.
Impact:
- Provides a comprehensive overview of tubulin inhibitors for cancer treatment.
- Highlights the therapeutic potential of targeting tubulin in oncology.
- Informs future research and drug development strategies for anticancer therapies.
More Related Videos
06:02Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
Published on: February 20, 2017
07:54Purification of Tubulin with Controlled Posttranslational Modifications and Isotypes from Limited Sources by Polymerization-Depolymerization Cycles
Published on: November 5, 2020
Related Concept Videos
01:15Drugs that Stabilize Microtubules
01:10Drugs that Destabilize Microtubules
01:45Destabilization of Microtubules